Pikumil Pikumil
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Reels
  • Blogs
  • Offres
  • Emplois
  • Courses
  • Forums
  • Film
  • Jeux
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Akshay Gorde Ajouter une nouvelle offre d'emploi Health
    2026-09-21 17:21:19 -
    Erythropoietin (EPO) Drugs Market Growth, Overview and Forecast Analysis By Fact.MR
    ROCKVILLE, MARYLAND , Sept 21, 2026 — The global erythropoietin (EPO) drugs market is projected to grow from USD 13.8 billion in 2026 to USD 22.7 billion by 2036, registering a compound annual growth rate (CAGR) of 5.1% during the forecast period. The market was valued at USD 13.1 billion in 2025, driven by recurring renal-anemia treatment demand. Absolute opportunity is...
    0 Commentaires 0 Parts 50 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Matt Watson Ajouter une nouvelle offre d'emploi Health
    2026-09-18 12:23:03 -
    Erythropoietin Drugs Market 2026: Size, Share, Industry Trends, Growth and Forecast to 2034
    According to IMARC Group, the global erythropoietin drugs market size reached USD 12,097.4 Million in 2025 and is projected to reach USD 18,184.2 Million by 2034, expanding at a CAGR of 4.49% during 2026-2034. This steady growth trajectory reflects the rising global burden of chronic kidney disease and cancer, continuous innovation in biopharmaceutical research, and the accelerating shift...
    0 Commentaires 0 Parts 57 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Matt Watson Ajouter une nouvelle offre d'emploi Health
    2026-09-22 12:39:33 -
    Erythropoietin Drugs Market Size, Share, Latest Insights and Forecast 2026-2034
    According to IMARC Group, the global erythropoietin drugs market size reached USD 12,097.4 Million in 2025 and is projected to reach USD 18,184.2 Million by 2034, expanding at a CAGR of 4.49% during 2026-2034. This steady growth trajectory reflects the rising global burden of chronic kidney disease and cancer, continuous innovation in biopharmaceutical research, and the accelerating shift...
    0 Commentaires 0 Parts 61 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2026 Pikumil French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Bengali
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire